453 related articles for article (PubMed ID: 20043850)
1. Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing.
Dong L; Jensen RV; De Rienzo A; Gordon GJ; Xu Y; Sugarbaker DJ; Bueno R
BMC Med Genet; 2009 Dec; 10():149. PubMed ID: 20043850
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications.
Suraokar MB; Nunez MI; Diao L; Chow CW; Kim D; Behrens C; Lin H; Lee S; Raso G; Moran C; Rice D; Mehran R; Lee JJ; Pass HI; Wang J; Momin AA; James BP; Corvalan A; Coombes K; Tsao A; Wistuba II
Ann Oncol; 2014 Jun; 25(6):1184-92. PubMed ID: 24669013
[TBL] [Abstract][Full Text] [Related]
3. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.
Cheng YY; Wright CM; Kirschner MB; Williams M; Sarun KH; Sytnyk V; Leshchynska I; Edelman JJ; Vallely MP; McCaughan BC; Klebe S; van Zandwijk N; Lin RC; Reid G
Mol Cancer; 2016 Jun; 15(1):44. PubMed ID: 27245839
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia.
Alì G; Borrelli N; Riccardo G; Proietti A; Pelliccioni S; Niccoli C; Boldrini L; Lucchi M; Mussi A; Fontanini G
J Thorac Oncol; 2013 Nov; 8(11):1389-95. PubMed ID: 24084442
[TBL] [Abstract][Full Text] [Related]
5. ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.
Cheng YY; Kirschner MB; Cheng NC; Gattani S; Klebe S; Edelman JJ; Vallely MP; McCaughan BC; Jin HC; van Zandwijk N; Reid G
J Thorac Oncol; 2013 Oct; 8(10):1317-28. PubMed ID: 24457242
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
Laszlo V; Hoda MA; Garay T; Pirker C; Ghanim B; Klikovits T; Dong YW; Rozsas A; Kenessey I; Szirtes I; Grusch M; Jakopovic M; Samarzija M; Brcic L; Kern I; Rozman A; Popper H; Zöchbauer-Müller S; Heller G; Altenberger C; Ziegler B; Klepetko W; Berger W; Dome B; Hegedus B
J Pathol; 2015 Oct; 237(2):203-14. PubMed ID: 26011651
[TBL] [Abstract][Full Text] [Related]
7. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
[TBL] [Abstract][Full Text] [Related]
8. Sequential binary gene ratio tests define a novel molecular diagnostic strategy for malignant pleural mesothelioma.
De Rienzo A; Richards WG; Yeap BY; Coleman MH; Sugarbaker PE; Chirieac LR; Wang YE; Quackenbush J; Jensen RV; Bueno R
Clin Cancer Res; 2013 May; 19(9):2493-502. PubMed ID: 23493352
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome sequencing of the Microarray Quality Control (MAQC) RNA reference samples using next generation sequencing.
Mane SP; Evans C; Cooper KL; Crasta OR; Folkerts O; Hutchison SK; Harkins TT; Thierry-Mieg D; Thierry-Mieg J; Jensen RV
BMC Genomics; 2009 Jun; 10():264. PubMed ID: 19523228
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive study of alternative splicing in malignant pleural mesothelioma identifies potential therapeutic targets in a new cluster with poor survival.
Shao MM; Qiao X; Chen QY; Yi FS
Thorac Cancer; 2022 Aug; 13(16):2318-2330. PubMed ID: 35790883
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
[TBL] [Abstract][Full Text] [Related]
12. RNA sequencing and transcriptome arrays analyses show opposing results for alternative splicing in patient derived samples.
Nazarov PV; Muller A; Kaoma T; Nicot N; Maximo C; Birembaut P; Tran NL; Dittmar G; Vallar L
BMC Genomics; 2017 Jun; 18(1):443. PubMed ID: 28587590
[TBL] [Abstract][Full Text] [Related]
13. A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma.
Melaiu O; Cristaudo A; Melissari E; Di Russo M; Bonotti A; Bruno R; Foddis R; Gemignani F; Pellegrini S; Landi S
Mutat Res; 2012; 750(2):132-140. PubMed ID: 22198210
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome sequencing of malignant pleural mesothelioma tumors.
Sugarbaker DJ; Richards WG; Gordon GJ; Dong L; De Rienzo A; Maulik G; Glickman JN; Chirieac LR; Hartman ML; Taillon BE; Du L; Bouffard P; Kingsmore SF; Miller NA; Farmer AD; Jensen RV; Gullans SR; Bueno R
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3521-6. PubMed ID: 18303113
[TBL] [Abstract][Full Text] [Related]
15. Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis.
Bruno R; Alì G; Giannini R; Proietti A; Lucchi M; Chella A; Melfi F; Mussi A; Fontanini G
Oncotarget; 2017 Jan; 8(2):2758-2770. PubMed ID: 27835874
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.
Gordon GJ; Rockwell GN; Jensen RV; Rheinwald JG; Glickman JN; Aronson JP; Pottorf BJ; Nitz MD; Richards WG; Sugarbaker DJ; Bueno R
Am J Pathol; 2005 Jun; 166(6):1827-40. PubMed ID: 15920167
[TBL] [Abstract][Full Text] [Related]
17. EasyCluster2: an improved tool for clustering and assembling long transcriptome reads.
Bevilacqua V; Pietroleonardo N; Giannino E; Stroppa F; Simone D; Pesole G; Picardi E
BMC Bioinformatics; 2014; 15 Suppl 15(Suppl 15):S7. PubMed ID: 25474441
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs dysregulation in human malignant pleural mesothelioma.
Balatti V; Maniero S; Ferracin M; Veronese A; Negrini M; Ferrocci G; Martini F; Tognon MG
J Thorac Oncol; 2011 May; 6(5):844-51. PubMed ID: 21358347
[TBL] [Abstract][Full Text] [Related]
19. Analysis of microRNA expression signatures in malignant pleural mesothelioma, pleural inflammation, and atypical mesothelial hyperplasia reveals common predictive tumorigenesis-related targets.
Ramírez-Salazar EG; Salinas-Silva LC; Vázquez-Manríquez ME; Gayosso-Gómez LV; Negrete-Garcia MC; Ramírez-Rodriguez SL; Chávez R; Zenteno E; Santillán P; Kelly-García J; Ortiz-Quintero B
Exp Mol Pathol; 2014 Dec; 97(3):375-85. PubMed ID: 25236577
[TBL] [Abstract][Full Text] [Related]
20. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma.
Gordon GJ; Jensen RV; Hsiao LL; Gullans SR; Blumenstock JE; Ramaswamy S; Richards WG; Sugarbaker DJ; Bueno R
Cancer Res; 2002 Sep; 62(17):4963-7. PubMed ID: 12208747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
